2 results for "YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD."

Favicon for changeflow.com

Bioactive Phenolate Ionic Complexes, 21 Claims, US12606536B2

The USPTO granted Patent US12606536B2 to Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. for bioactive phenolate ionic complexes. The patent covers isolated materials comprising phenolate species and counter ions in the form of metal salts, phosphonium, or ammonium. Twenty-one claims were allowed.

Routine Rule Intellectual Property
Favicon for changeflow.com

Indoline Derivatives for Disease Treatment

The USPTO granted patent US12599584B2 to Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. covering indoline derivatives and pharmaceutical compositions for treating diseases associated with oxidative stress, immune response, NO release, and pro-inflammatory cytokines. The patent names Marta Weinstock-Rosin, Abraham Nudelman, and Shani Zeeli as inventors and was filed on January 19, 2017. This grant establishes intellectual property protection for the therapeutic applications of these indoline compounds.

Routine Notice Intellectual Property

Get alerts for "YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD."

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

Filters

Get alerts for "YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD."

We'll email you when new changes match "YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.".

Free. Unsubscribe anytime.

You're subscribed!